Compounds > 6-[[5-fluoro-2-(3-4-5-trimethoxyanilino)-4-pyrimidinyl]amino]-2-2-dimethyl-4H-pyrido[3-2-b][1-4]oxazin-3-one

6-[[5-fluoro-2-(3-4-5-trimethoxyanilino)-4-pyrimidinyl]amino]-2-2-dimethyl-4H-pyrido[3-2-b][1-4]oxazin-3-one and Hypersensitivity

6-[[5-fluoro-2-(3-4-5-trimethoxyanilino)-4-pyrimidinyl]amino]-2-2-dimethyl-4H-pyrido[3-2-b][1-4]oxazin-3-one has been researched along with Hypersensitivity* in 1 studies

Other Studies

1 other study(ies) available for 6-[[5-fluoro-2-(3-4-5-trimethoxyanilino)-4-pyrimidinyl]amino]-2-2-dimethyl-4H-pyrido[3-2-b][1-4]oxazin-3-one and Hypersensitivity

ArticleYear
Discovery and development of spleen tyrosine kinase (SYK) inhibitors.
    Journal of medicinal chemistry, 2012, Apr-26, Volume: 55, Issue:8

    Topics: Animals; Autoimmune Diseases; Drug Discovery; Enzyme Inhibitors; Humans; Hypersensitivity; Intracellular Signaling Peptides and Proteins; Mice; Protein-Tyrosine Kinases; Structure-Activity Relationship; Syk Kinase; ZAP-70 Protein-Tyrosine Kinase

2012